ZEPP

Zepp Health Corp

Add to Watchlist

Advanced Chart

51.300

+3.3(6.875%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

51.550

Open

47.100

VWAP

49.47

Vol

470.60K

Mkt Cap

748.54M

Low

46.490

Amount

23.28M

EV/EBITDA(TTM)

Total Shares

59.98M

884.14M

EV/OCF(TTM)

P/S(TTM)

4.12

Zepp Health Corp, formerly Huami Corp, is a Netherlands-based company primarily engaged in the consumer electronics and digital health technology industry. The Company focuses on developing smart wearable devices and digital health management platforms. Their key product is the Zepp Digital Health Management Platform, which is a cloud-based system integrating smart devices, biometric sensors, Artificial Intelligence (AI) chips, and data algorithms. It aims to provide users with 24/7 actionable insights to support health, fitness, and wellness management. The platform powers a range of products including smartwatches, fitness bands, smart rings, and hearables under the Amazfit and Zepp brand names. Additionally, the Company offers AI-driven services such as Zepp Aura for sound-based wellness and Zepp Clarity for hearing health. The Company has two reportable segments the Xiaomi wearable products segment and Self-branded products and others segment.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2024Q4

FY2024Q3

FY2024Q2

0.228

+583.45%

0.164

+17.55%

0.024

-104.5%

Estimates Revision

The market is revising No Change the revenue expectations for Zepp Health Corporation (ZEPP) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 2002.46%.

Revenue Estimates for FY2025

No Change

0.00%

In Past 3 Month

EPS Estimates for FY2025

No Change

0.00%

In Past 3 Month

Stock Price

Go Up

+2002.46%

In Past 3 Month

1 Analyst Rating

Wall Street analysts forecast ZEPP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ZEPP is 60.23 USD with a low forecast of 60.23 USD and a high forecast of 60.23 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 51.300

Low

60.23

Averages

60.23

High

60.23

Current: 51.300

Low

60.23

Averages

60.23

High

60.23

The End

No Data

Valuation Metrics

The current forward P/E ratio for Zepp Health Corp (ZEPP.N) is -500.49, compared to its 5-year average forward P/E of -11.39. For a more detailed relative valuation and DCF analysis to assess Zepp Health Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-11.39

Current PE

-500.49

Overvalued PE

59.76

Undervalued PE

-82.54

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-6.08

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

26.62

Undervalued EV/EBITDA

-38.78

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.38

Current PS

0.00

Overvalued PS

0.79

Undervalued PS

-0.04